Metastatic melanoma treatment: Combining old and new therapies.

Davey, Ryan J; van der Westhuizen, Andre; Bowden, Nikola A

Davey, Ryan J; van der Westhuizen, Andre; Bowden, Nikola A.

Davey RJ; Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, Australia.
van der Westhuizen A; Department of Medical Oncology, Calvary Mater Hospital, Newcastle, NSW, Australia.
Bowden NA; Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, NSW, Australia. Electronic address: Nikola.Bowden@newcastle.edu.au.

Crit Rev Oncol Hematol ; 98: 242-53, 2016 Feb.

Article en En | MEDLINE | ID: mdl-26616525

Asunto(s)

Melanoma/tratamiento farmacológico; Terapia Molecular Dirigida; GTP Fosfohidrolasas/antagonistas & inhibidores; Humanos; Inmunoterapia; Inmunoterapia Adoptiva; Interleucina-2/uso terapéutico; Melanoma/secundario; Proteínas de la Membrana/antagonistas & inhibidores; Quinasas de Proteína Quinasa Activadas por Mitógenos/antagonistas & inhibidores; Mutación; Fosfohidrolasa PTEN/genética; Receptor de Muerte Celular Programada 1/antagonistas & inhibidores; Proteínas Proto-Oncogénicas B-raf/antagonistas & inhibidores

Palabras clave

Combination therapy; Immunotherapy; Melanoma; Targeted therapy; Treatment

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapia Molecular Dirigida / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google